Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain-Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review. - Prado MB Jr; Adiao KJB; Turalde CWR; Dasig DA (Acta neurologica Belgica, 2024)